---
title: "Vor Biopharma reports Q2 results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295613869.md"
description: "Vor Biopharma reports Q2 results"
datetime: "2026-08-12T05:01:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295613869.md)
  - [en](https://longbridge.com/en/news/295613869.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295613869.md)
generator: "portal-rs"
---

# Vor Biopharma reports Q2 results


### Related Stocks

- [VOR.US](https://longbridge.com/en/quote/VOR.US.md)

## Related News & Research

- [Vor Bio highlights telitacicept BAFF/APRIL inhibitor as lead program in B cell-driven autoimmune diseases](https://longbridge.com/en/news/298307942.md)
- [Vor Bio files automatic mixed securities shelf](https://longbridge.com/en/news/298086293.md)
- [Vor Bio completes enrollment in Phase 3 UPSTREAM MG trial for telitacicept in generalized myasthenia gravis](https://longbridge.com/en/news/298307070.md)
- [Prediction: This high-yield Dow dividend stock will become a dividend king before the end of the year](https://longbridge.com/en/news/298812498.md)
- [Barings Global Short Duration High Yield Fund declares $0.1223 dividend](https://longbridge.com/en/news/298729681.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**